Related Experiment Video
Updated: Jul 31, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas
Dipen Maru1, Tsung-Teh Wu, Amanda Canada
1Department of Pathology, the University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
Appendiceal adenocarcinomas are uncommon, and the genetic alterations present in these tumors are not well characterized. We studied genetic alterations including loss of chromosome 18q (location of DCC, DPC4, and JV-18 genes), and mutations of the DPC4 (SMAD4) and beta-catenin genes in 28 appendiceal adenocarcinomas, consisting of 17 mucinous and 11 nonmucinous carcinomas. Chromosome 18q loss was present in 57% (12/21) of appendiceal carcinomas including 54% (7/13) of mucinous and 63% (5/8) of nonmucinous carcinomas. Mutation of the DPC4 gene was present in 14% (three of 22) of the carcinomas occurring in one tumor with chromosome 18q loss and in two with unassessed chromosome 18q status. beta-catenin gene mutation was present in 0% (0 of 25) of the carcinomas. Chromosome 18q loss status was not associated with any clinicopathological features. The presence of chromosome 18q loss and DPC4 mutations in appendiceal adenocarcinomas suggests involvement of DPC4 and nearby genes on chromosome 18q (DCC and/or JV-18) in the pathogenesis of appendiceal adenocarcinomas.
Insights
Appendiceal adenocarcinomas, though rare, show significant genetic alterations. Chromosome 18q loss and DPC4 gene mutations are implicated in the development of these tumors.
Area of Science:
- Oncology
- Genetics
- Gastroenterology
Background:
- Appendiceal adenocarcinomas are rare tumors with poorly understood genetic profiles.
- Understanding genetic alterations is crucial for elucidating appendiceal cancer pathogenesis.
Purpose of the Study:
- To investigate genetic alterations in appendiceal adenocarcinomas.
- To analyze chromosome 18q loss and mutations in DPC4 (SMAD4) and beta-catenin genes.
Main Methods:
- Analysis of 28 appendiceal adenocarcinoma samples (17 mucinous, 11 nonmucinous).
- Genetic analysis included assessment for chromosome 18q loss and mutations in DPC4 and beta-catenin genes.
Main Results:
- Chromosome 18q loss was observed in 57% of appendiceal carcinomas.
- DPC4 gene mutations were found in 14% of the analyzed carcinomas.
- No beta-catenin gene mutations were detected; 18q loss was not linked to clinicopathological features.
Conclusions:
- The study suggests that chromosome 18q loss and DPC4 mutations play a role in appendiceal adenocarcinoma development.
- Genes such as DPC4, DCC, and JV-18 on chromosome 18q may be involved in the pathogenesis of these rare cancers.
More Related Videos
05:21Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
Published on: October 6, 2014
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
Related Concept Videos
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Appendicitis